Host David Harlow speaks with Joel Diamond, CMO at 2bPrecise about bringing genetic testing information in a meaningful way to the physician at the point of care, within the EMR.

To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio.”

Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Harlow on Healthcare

Harlow On Healthcare: Joel Diamond MD, CMO at 2bPrecise

In the finale of our series "Conversations about Hypertrophic Cardiomyopathy", Dr Ankur Kalra welcomes, Dr Anjali Tiku Owens, for a dynamic and practical discussion.

Dr Owens is Medical Director of the Center for Inherited Cardiac Disease and Associate Professor of Medicine at the Hospital of the University of Pennsylvania.

This series is supported by an unrestricted educational grant from Bristol Myers Squibb. Please see www.camzyosrems.com for important safety information.

In this week’s episode, Dr Kalra and Dr Owens take us on a journey through the complexities of hypertrophic cardiomyopathy (HCM), with focus on the diagnostic challenges and breakthroughs in this field.
Emphasising with the critical importance of making accurate diagnoses, Dr Owens shares her insights into identifying the common mimickers of HCM through a structured approach starting with taking the patients history.
As the conversation delves deeper, Dr Owens discusses the various diagnostic tools and tests used to rule out other conditions and uncover the underlying aetiology. She navigates us through the algorithm for interpreting genetic test results, differentiating pathogenic variants, benign variants and variants of uncertain significance (VUS). Dr Owens talks about the wider implications for family members and the cases in which she recommends screening.
Dr Kalra asks Dr Owens about her approach to exercise in HCM patients. Additionally, they cover the debated topic of defibrillator therapy and the use of HCM Risk-SCD risk calculator.
Dr Owens provides an overview of the treatment paradigms for HCM, touching on haemodynamic classifications, symptomatology and the evaluation of sudden death risk.

What are the most common mimickers of HCM? What is Dr Owens and her heart team approach to decision making? What is the role of genetic testing in patients with HCM?

This content is intended for US-based physicians.

EP 97: Conversations about HCM: Differential Diagnosis, Genetic Testing & Patient-centric Therapy

In this special episode of our podcast, Hui-Ling Ou is joined by Isobel Turbin to talk about inherited pancreatic cancer, genetic testing, and genetic counselling. They also discuss which genetic tests are currently available, why these genes are important, and how testing results may help pancreatic cancer patients.

Dr Hui-Ling Ou is the Programme Manager for the Pancreatic Cancer Programme at the CRUK Cambridge Centre at the University of Cambridge, UK.

Isobel Turbin is a Principal Genetic Counsellor within the East Anglia Regional Genetics Service, UK. She currently holds cancer genetic, general genetic, and prenatal genetic clinics at Addenbrooke's Hospital in Cambridge, UK, as well as monthly general genetic clinics in King's Lynn, UK. Isobel is also the Education and Training Co-lead in the East Anglian Genetic Counselling Team.

Useful links mentioned in this podcast episode:

National Genomic Test Directory: www.england.nhs.uk/publication/national-genomic-test-directories

EUROPAC: www.europactrial.com

Genetic Alliance UK: www.geneticalliance.org.uk

Genetic and Genomic Testing (NHS webpage): www.nhs.uk/conditions/genetic-and-genomic-testing

Clinical Genetics at Cambridge University Hospitals NHS Foundation Trust: www.cuh.nhs.uk/our-services/clinical-genetics

Ask me anything about... cancer

Ask me anything about... genetic testing in pancreatic cancer

Do you know why your allergy medicine isn’t working for you and what you can do about it? Tune in for an inspiring discussion with Dr. Sue Ojageer on the power of precision medicine. 

Moments with Marianne airs in the Southern California area on KMET1490AM & 98.1 FM, an ABC Talk News Radio affiliate! 

Dr. Sue Ojageer received a Doctorate of Pharmacy from St. John's University and moved to Texas in 2014 where she worked at Walgreens as a pharmacist. When the pandemic hit in 2020, she began to feel burned out and started posting on social media to connect with people and help them get answers quickly.  She founded a revolutionary health practice, PharmaSue, and offers PGX testing (genetic testing) to help people get the right medicine and personalize patient care.  https://www.pharmasue.com

 For more show information visit:
www.MariannePestana.com

#book #speaker #radioshow #MomentsWithMarianne #kmet1490am #allergies #PharmaSue

Why Your Allergy Medicine Isn’t Working and How To Find The Solution with Dr. Sue Ojageer

On Wednesday, 16 October 2024, Andre Ling, the founder of MyDNA, went on Kiss92 FM’s popular radio show 'On Your Way with Joshua Simon' to discuss the significance of DNA testing and its transformative impact on personal health and well-being. During the segment, Andre Ling emphasised how DNA testing can empower individuals with insights into their genetic makeup, helping them make informed decisions about their lifestyle, nutrition, and healthcare choices.

MyDNA | Kiss92 Singapore | On Yor Way with Joshua Simon

Dr. Mazen IVF Clinic offers comprehensive genetic testing during pregnancy to help identify potential genetic conditions and ensure a healthy pregnancy. Their advanced screening techniques, including non-invasive prenatal testing (NIPT), provide valuable insights into the baby's health, allowing parents to make informed decisions. With a focus on personalized care and accurate results, Dr. Mazen and his team guide expectant parents through every step. Visit their website to learn more about genetic testing options and how they can support your pregnancy journey.

Visit now: https://drmazenivf.com/genetic-testing-pregnancy/


Genetic Testing for Pregnancy at Dr. Mazen IVF Clinic

Dr. Mazen IVF Clinic provides advanced genetic testing for pregnant women, offering valuable insights into the health of both mother and baby. These tests help detect genetic conditions such as Down syndrome, cystic fibrosis, and other hereditary disorders early in pregnancy. Dr. Mazen and his team use the latest screening technologies to ensure accurate results and informed decision-making. Focusing on patient care and support, the clinic guides expectant parents through the process, providing peace of mind. Trust Dr Mazen IVF Clinic for reliable genetic testing during pregnancy in Dubai.

Visit now: https://drmazenivf.com/genetic-testing-pregnancy/

Genetic Testing During Pregnancy in Dubai – Dr. Mazen IVF

Dr. Mazen IVF offers advanced genetic testing for pregnancy to ensure the health of both mother and baby. Their expert team provides non-invasive screenings to detect potential genetic disorders early, allowing for peace of mind during pregnancy. With cutting-edge technology and a compassionate approach, Dr. Mazen IVF helps expectant parents make informed decisions. The tests are safe, accurate, and tailored to individual needs, providing crucial information about the baby’s health. Trust their expertise in genetic testing to guide you through a healthy pregnancy journey. Get in touch with Dr. Mazen IVF today for more details!

Visit: https://drmazenivf.com/genetic-testing-pregnancy/


Comprehensive Genetic Testing for Pregnancy  Dr Mazen IVF

23andMe bankruptcy a sad story.  Today's Techstination.

23andMe bankruptcy a sad story

Genetic testing during pregnancy helps detect potential genetic conditions early, ensuring a healthier pregnancy and baby. Dr. Mazen IVF offers advanced prenatal genetic screening and diagnostic tests, providing parents with crucial insights and peace of mind. From non-invasive prenatal testing (NIPT) to carrier screening, their expert team ensures accurate results and personalized care. Learn more about genetic testing for pregnancy at Dr. Mazen IVF!

Visit here: https://drmazenivf.com/genetic-testing-pregnancy/


Genetic Testing in Pregnancy – Expert Care at Dr. Mazen IVF

In this moving episode of Comfort Conversations, host Erin Youngblood sits down with Kim Martin, a former college instructor living with early-stage Alzheimer's, and Pat Demerest, caregiver and founder of the Durango Dementia Coalition. Together, they offer a deeply personal look at life with dementia — from surprising diagnoses and emotional lows to resilience, support systems, and hopeful innovations.

Kim shares how a 23andMe test revealed her genetic predisposition, leading to her Alzheimer’s diagnosis and the challenges of accessing treatment in rural Durango. Pat opens up about her nine-year journey caring for her husband, and how guilt gave way to relief when he finally found joy in professional care. The two women offer honesty, advocacy, and encouragement for others navigating similar paths.

This conversation highlights the importance of early diagnosis, community resources like the Durango Dementia Coalition, and new Medicare initiatives like the GUIDE model that aim to make dementia care more compassionate and navigable.

Episode 5: Alzheimers and Dementia

Genetic testing in the UAE is becoming a vital part of fertility treatment, helping identify inherited conditions and chromosomal abnormalities. The cost of genetic testing can vary depending on the type of test, such as Preimplantation Genetic Testing (PGT) or carrier screening. At clinics like Dr. Mazen’s in Dubai, these tests are often recommended to improve IVF success rates and ensure healthy pregnancies. While prices differ based on specific procedures and laboratory fees, patients are encouraged to consult directly with fertility specialists to understand the most suitable options and associated costs for their reproductive journey.

Visit here: https://drmazenivf.com/genetic-testing-pregnancy/

Understanding Genetic Testing Cost in the UAE for Fertility Care

In this essential episode of Parallax, Dr Ankur Kalra is joined by Dr Carolyn Ho, Professor of Medicine at Harvard Medical School and Medical Director of the Cardiovascular Genetics Program at Brigham and Women's Hospital, for a comprehensive discussion on how genetic testing is reshaping hypertrophic cardiomyopathy management.

The conversation explores the VANISH HCM trial results, which showed that valsartan can slow disease progression in young, asymptomatic individuals with early sarcomeric HCM. Dr Ho discusses how this evidence influenced the 2024 HCM guidelines and created new opportunities for disease-modifying therapy before clinical symptoms appear. The episode also examines emerging gene-based therapeutics, from current adeno-associated virus approaches to future CRISPR technologies that could address the underlying genetic causes of HCM.

Dr Ho addresses practical considerations for clinicians, including when to initiate genetic testing, how to manage family screening, and the promise of AI-assisted screening tools. The discussion highlights both current therapeutic options and the evolving landscape of precision medicine in inherited cardiovascular disease.

Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio
Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

EP 139: The Genetic Revolution in HCM: Mapping Family Risk to Targeted Treatment

Techstination is a daily report on consumer tech produced by Fred Fishkin.  Listen to full interviews and daily reports here and find more at www.techstination.com

My name is Aya Kanani and I live in Dubai. Are you looking for the best IVF doctors in Dubai? I know one of the best specialists with 18 years of experience in reproductive medicine. I have personal experience and he is one of the expert doctors running the best fertility clinic in Dubai. So, if you are in Dubai and looking for the same, visit the best IVF center in Dubai.

In a single moment your life can change!  “Moments with Marianne” is a transformative hour that covers an endless array of topics with the ‘best of the best.’ Her guest are leaders in their fields, ranging from inspirational authors, top industry leaders, business and spiritual entrepreneurs.  Each guest is gifted, and a true visionary!  A recognized leader in her own work, and while teaching others to develop, refocus, and grow; Marianne will bring the best guest, and sometimes a special surprise.  Don’t miss this – you never know just which ‘moment’ will change your life forever.

RADIO FOR THE HEALTHCARE INDUSTRY
Healthcare NOW Radio and Podcast Network offers discussions on the latest developments and trends impacting the industry including: health tech, health IT, healthcare innovation, healthcare policy, healthcare data security, telehealth, interoperability, biotech, med tech, value-based care, pharma, healthcare compliance, and much more. Shows are hosted by industry thought leaders. Guests are a "who's who" across the healthcare spectrum.  The listening audience is predominantly physician and hospital-based, and the healthcare industry at large.

‘Parallax’ (/ˈparəlaks/)-noun: the effect whereby the position or direction of an object appears to differ when viewed from different positions. Join Ankur Kalra, MD as he shows you a different side to cardiovascular care, management and science. Listen to Ankur’s conversations with legendary cardiologists, critical reviews of key congresses and late-breaking trials, and concise summaries. Published every second Monday of the month, this is your fix of reliable updates on all things cardiology by someone from a non-traditional background, who is always trying to look at it from new angles! Dear cardiologists, we want to make this podcast about you, and for you! Please email us critical thoughts, comments and questions for Ankur at podcast@radcliffe-group.com.

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

New tracks tagged #genetic testing